RankingsPricing
  1. JP-listed companies
  2. NANO MRNA Co.,Ltd.
  3. Financials
  4. Total liabilities

NANO MRNA Co.,Ltd.【JP:4571】

Market cap
¥10.3B
P/E ratio
-9.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 20251,257-23.81%
Mar 31, 20241,650+7.77%
Mar 31, 20231,531-2.45%
Mar 31, 20221,569+388.91%
Mar 31, 2021321+82.80%
Mar 31, 2020176-93.47%
Mar 31, 20192,689-9.33%
Mar 31, 20182,965+3.25%
Mar 31, 20172,872-11.83%
Mar 31, 20163,258+1512.43%
Mar 31, 2015202

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)